NYU Langone Health, Diabetes & Endocrine Associates, New York City, New York, USA.
Curr Opin Endocrinol Diabetes Obes. 2021 Feb 1;28(1):30-34. doi: 10.1097/MED.0000000000000605.
The goal of this article is to review recent research of technology use, including insulin pumps, continuous glucose monitors, and smartpens, for pregnant women with preexisting type 1 diabetes.
Recent research shows that there may be benefits from technology use in type 1 diabetes pregnancies given the changes in insulin sensitivity throughout the span of pregnancy as well as allowing for more monitoring to allow for sooner titration of insulin doses.
There may be utility in incorporation of technology during pregnancy with appropriate medical guidance. Additional research would be helpful to further assess the ability of newer automated insulin systems to aid in tight glucose management goals during pregnancy and show value in receiving FDA approval.
本文旨在回顾近期关于技术应用的研究，包括胰岛素泵、连续血糖监测仪和智能笔，这些技术应用于患有 1 型糖尿病的孕妇。
近期研究表明，考虑到整个妊娠期间胰岛素敏感性的变化，以及更多的监测以允许更早地调整胰岛素剂量，技术应用于 1 型糖尿病妊娠可能具有益处。
在适当的医疗指导下，怀孕期间纳入技术可能具有实用性。进一步的研究将有助于更好地评估新型自动化胰岛素系统在帮助实现妊娠期间严格血糖管理目标方面的能力，并显示出获得 FDA 批准的价值。
